Pharming Group to participate in April investor conferences
Conference attendancePharming Group N.V. today announced that its management will participate in the following investor conferences in the month of April:
2026
Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Conference attendancePharming Group N.V. today announced its participation in the Oppenheimer 36th Annual Healthcare Life Sciences Conference being held virtually on February 25-26, 2026.
2025
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
Conference attendancePharming Group N.V. today announced its participation in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025 in New York City. This invitation-only event brings together innovative companies and investors focused on rare diseases.
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
Conference attendancePharming Group N.V. announces that Pharming management will participate in the Jefferies Global Healthcare Conference in London, UK, on November 17-20, 2025.
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Conference attendancePharming Group N.V. today announced that 12 abstracts have been accepted for presentation at the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting taking place in Orlando, Florida on November 6-10.
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
Conference attendancePharming Group N.V. announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025.
Pharming Group to participate in August investor conference
Conference attendancePharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of August:
Pharming Group to participate in June investor conferences
Conference attendancePharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
Conference attendancePharming Group N.V. announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the Clinical Immunology Society (CIS), taking place May 1-4, 2025 in Philadelphia, PA.
Pharming Group to participate in April investor conferences
Conference attendancePharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of April: